Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan
Saved in:
Main Authors: | Makoto Nagata, Ryo Yamaguchi, Makiko Usami, Mami Orimo, Masato Ishida |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Allergology International |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893024000844 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Final Analysis of Post‐Marketing Surveillance for Avelumab + Axitinib in Patients With Renal Cell Carcinoma in Japan
by: Norio Nonomura, et al.
Published: (2025-01-01) -
Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma
by: Kenji Mizumura, et al.
Published: (2025-01-01) -
Avelumab + axitinib treatment in older patients with advanced renal cell carcinoma in Japan: Subgroup analyses of post‐marketing surveillance data by age
by: Mototsugu Oya, et al.
Published: (2025-01-01) -
Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics
by: Michael E. Wechsler, et al.
Published: (2024-12-01) -
Secondary Syphilis with Eosinophilia Complicated by Severe Jarisch–Herxheimer Reaction
by: Anthony Elias, et al.
Published: (2020-01-01)